Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues AEON Q4 2025 Earnings WiderThanExpected Loss as Biotech Continues PreRevenue Phase TTAN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Recurring Revenue Growth FLNC Q1 2026 Earnings Slightly BetterThanExpected Loss Drives Positive Market Reaction PRCT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment JB Hunt Q1 2026 Earnings EPS Slightly Beats Estimates Amid Challenging Freight Market